Association Between Low-Dose Aspirin Use and Early Renal Injury Biomarkers in Patients with Type 2 Diabetes Mellitus: A Retrospective Matched Cohort Study
Open Access
- 1 July 2026
- journal article
- research article
- Published by Taylor & Francis in Diabetes, Metabolic Syndrome and Obesity
- Vol. ume 19, 1-8
Abstract
Purpose: Microalbuminuria and urine albumin-to-creatinine ratio (UACR) are important markers for early diabetic kidney disease (DKD) in patients with type 2 diabetes mellitus (T2DM). Aspirin (acetylsalicylic acid; ASP) has been associated with anti-inflammatory and metabolic effects in patients with T2DM. This study investigated the association between low-dose ASP use and renal injury markers in patients with T2DM. Methods: A retrospective matched cohort study was conducted in 60 Taiwanese patients with T2DM. Patients receiving low-dose ASP (100 mg/day) were matched 1:1 with controls according to sex, age, height, weight, body mass index, and duration of diabetes. Metabolic outcomes and renal injury markers, including serum creatinine, urine microalbumin, and urine albumin-to-creatinine ratio (UACR), were evaluated during follow-up. Results: Compared with the DM group, the ASP group demonstrated lower HbA1c and total cholesterol levels during follow-up. In renal outcome analysis, urine microalbumin levels were significantly lower in the ASP group than in the DM group at follow-up (p = 0.039). A trend toward improved UACR was also observed in the ASP group. Conclusion: Low-dose ASP use was associated with favorable changes in glycemic control and early renal injury markers in patients with T2DM. Lower urine microalbumin levels and a trend toward improved UACR were observed in the ASP group during follow-up. Although microalbuminuria may be influenced by multiple metabolic and cardiovascular factors, the present findings suggest that low-dose ASP therapy may have potential metabolic and renal associations in patients with T2DM. Further prospective studies are warranted to validate these findings and to explore the underlying mechanisms and their clinical relevance.Keywords
This publication has 25 references indexed in Scilit:
- Diet, Inflammation, and Glycemic Control in Type 2 Diabetes: An Integrative Review of the LiteratureJournal of Nutrition and Metabolism, 2012
- Prevalence and Association of Microalbuminuria in Essential Hypertensive PatientsNorth American Journal of Medical Sciences, 2012
- Changes in the Prevalence of the Most Common Causes of Chronic Liver Diseases in the United States From 1988 to 2008Clinical Gastroenterology and Hepatology, 2011
- Association Between Insulin Resistance and Development of Microalbuminuria in Type 2 DiabetesDiabetes Care, 2011
- Aspirin Is Associated With Reduced Cardiovascular and All-Cause Mortality in Type 2 Diabetes in a Primary Prevention SettingDiabetes Care, 2009
- The Effect of Aspirin on the Antiproteinuric Properties of Enalapril in Microalbuminuric Type 2 Diabetic PatientsDiabetes Care, 2007
- Reduction in Microalbuminuria as an Integrated Indicator for Renal and Cardiovascular Risk Reduction in Patients With Type 2 DiabetesDiabetes, 2007
- Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetesJournal of Clinical Investigation, 2002
- INHIBITION OF GLYCATION OF ALBUMIN AND HEMOGLOBIN BY ACETYLATION INVITRO AND INVIVO1986
- Acetyl-salicylic acid impairs insulin-mediated glucose utilization and reduces insulin clearance in healthy and non-insulin-dependent diabetic manDiabetologia, 1985